Community case management of fast-breathing pneumonia with 3 days oral amoxicillin vs 5 days cotrimoxazole in children 2-59 months of age in rural Pakistan: A cluster randomized trial
暂无分享,去创建一个
Z. Bhutta | S. Soofi | A. Rizvi | I. Ahmed | Sheraz Ahmed | Shabina Ariff | Sajid Muhammed
[1] S. Cousens,et al. Global, regional, and national causes of under-5 mortality in 2000–19: an updated systematic analysis with implications for the Sustainable Development Goals , 2021, The Lancet. Child & adolescent health.
[2] Y. Nisar. Community-based amoxicillin treatment for fast breathing pneumonia in young infants 7–59 days old: a cluster randomised trial in rural Bangladesh, Ethiopia, India and Malawi , 2021, BMJ Global Health.
[3] Asad Ali,et al. Pathobiome driven gut inflammation in Pakistani children with Environmental Enteric Dysfunction , 2019, PloS one.
[4] D. Thea,et al. Comparison of 3 Days Amoxicillin Versus 5 Days Co-Trimoxazole for Treatment of Fast-breathing Pneumonia by Community Health Workers in Children Aged 2–59 Months in Pakistan: A Cluster-randomized Trial , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[5] I. Rudan,et al. Global, regional, and national estimates of pneumonia morbidity and mortality in children younger than 5 years between 2000 and 2015: a systematic analysis , 2018, The Lancet. Global health.
[6] Maureen H Diaz,et al. Causes and incidence of community-acquired serious infections among young children in south Asia (ANISA): an observational cohort study , 2018, The Lancet.
[7] Wafa Aftab,et al. Exploring health care seeking knowledge, perceptions and practices for childhood diarrhea and pneumonia and their context in a rural Pakistani community , 2018, BMC Health Services Research.
[8] A. Zaidi,et al. Ambulatory Treatment of Fast Breathing in Young Infants Aged <60 Days: A Double-Blind, Randomized, Placebo-Controlled Equivalence Trial in Low-Income Settlements of Karachi , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[9] W. Petri,et al. Respiratory viruses associated with severe pneumonia in children under 2 years old in a rural community in Pakistan , 2016, Journal of medical virology.
[10] Z. Bhutta,et al. Challenges in Implementation of the ANISA Protocol at the Matiari Site, Pakistan , 2016, The Pediatric infectious disease journal.
[11] A. Bari,et al. Effect of community mobilization on appropriate care seeking for pneumonia in Haripur, Pakistan , 2015, Journal of global health.
[12] Z. Bhutta,et al. Zinc supplementation fails to increase the immunogenicity of oral poliovirus vaccine: a randomized controlled trial. , 2015, Vaccine.
[13] L. Noblat,et al. Comparison of oral amoxicillin given thrice or twice daily to children between 2 and 59 months old with non-severe pneumonia: a randomized controlled trial. , 2014, The Journal of antimicrobial chemotherapy.
[14] V. Singhal,et al. Clinical Effectiveness of Co-trimoxazole vs. Amoxicillin in the Treatment of Non-Severe Pneumonia in Children in India: A Randomized Controlled Trial , 2013, International journal of preventive medicine.
[15] M. Lucero,et al. Global and regional burden of hospital admissions for severe acute lower respiratory infections in young children in 2010: a systematic analysis , 2013, The Lancet.
[16] Z. Bhutta,et al. Effectiveness of community case management of severe pneumonia with oral amoxicillin in children aged 2–59 months in Matiari district, rural Pakistan: a cluster-randomised controlled trial , 2012, The Lancet.
[17] S. Cousens,et al. Improvement of perinatal and newborn care in rural Pakistan through community-based strategies: a cluster-randomised effectiveness trial , 2011, The Lancet.
[18] L. Noblat,et al. Clinical failure among children with nonsevere community-acquired pneumonia treated with amoxicillin , 2010, Expert opinion on pharmacotherapy.
[19] I. Rudan,et al. The effect of case management on childhood pneumonia mortality in developing countries , 2010, International journal of epidemiology.
[20] E. Mulholland,et al. Recommendations for treatment of childhood non-severe pneumonia , 2009, The Lancet Infectious Diseases.
[21] Stefan Peterson,et al. Delayed care seeking for fatal pneumonia in children aged under five years in Uganda: a case-series study. , 2008, Bulletin of the World Health Organization.
[22] A. Sanabria,et al. Randomized controlled trial. , 2005, World journal of surgery.
[23] Jean-Pierre Habicht,et al. Improving antimicrobial use among health workers in first-level facilities: results from the multi-country evaluation of the Integrated Management of Childhood Illness strategy. , 2004, Bulletin of the World Health Organization.
[24] G. Agarwal,et al. Three day versus five day treatment with amoxicillin for non-severe pneumonia in young children: a multicentre randomised controlled trial , 2004, BMJ : British Medical Journal.
[25] Pakistan Multicentre Amoxicillin Short Course Therapy pneum group. Clinical efficacy of 3 days versus 5 days of oral amoxicillin for treatment of childhood pneumonia: a multicentre double-blind trial , 2002, The Lancet.
[26] Clinical efficacy of co-trimoxazole versus amoxicillin twice daily for treatment of pneumonia: a randomised controlled clinical trial in Pakistan , 2002, Archives of disease in childhood.
[27] P. New. Recommendations for treatment of childhood non-severe pneumonia , 2009 .
[28] I. Iqbal,et al. Randomized controlled trial of standard versus double dose cotrimoxazole for childhood pneumonia in Pakistan. , 2005, Bulletin of the World Health Organization.
[29] W. Straus,et al. Antimicrobial resistance and clinical effectiveness of co-trimoxazole versus amoxycillin for pneumonia among children in Pakistan: randomised controlled trial. Pakistan Co-trimoxazole Study Group. , 1998, Lancet.
[30] S. Qazi,et al. Standard management of acute respiratory infections in a children's hospital in Pakistan: impact on antibiotic use and case fatality. , 1996, Bulletin of the World Health Organization.